PEB | EASD

You are here

Poster Event B

Tuesday, 2 October 2018, 13:15 - 14:15, Poster Hall

PS 002 Diabetes prevalence

PS 008 Diabetes complications

PS 014 Genetics of diabetes

PS 020 Beta cell damage and protection

PS 026 Healthy diet for a healthy rodent

PS 032 Novel biomarkers

PS 038 Weight regulation and obesity in humans

PS 044 Are SGLT2 inhibitors effective and safe in type 1 diabetes?

PS 050 SGLT2 inhibitors: What do the CVOTs tell us?

PS 056 Metabolic effects of novel, dual and triple incretin agonists

PS 062 Incretin-based therapies: adherence and tolerability

PS 068 Faster acting insulins: state of the art

PS 074 Cost effectiveness in diabetes therapies

PS 080 Causes and consequences of hypoglycaemia

PS 086 Autonomic neuropathy

PS 092 Diabetic nephropathy: Predictions are hard to make

PS 098 Factors affecting cardiovascular outcome

PS 104 Complications and treatment

PS 110 Treating cardiovascular disease in diabetes

PS 116 Clinical aspects of NAFLD